港股创新药概念持续走低，歌礼制药跌超14%

Group 1 - The Hong Kong stock market for innovative drug concepts continues to decline, with notable drops in several companies [1] - Gilead Sciences saw a decline of over 14%, while China National Pharmaceutical Group fell by more than 9% [1] - Other companies such as BeiGene and CSPC Pharmaceutical Group also experienced declines [1]